Network meta-analysis ranks upadacitinib highest for efficacy in moderate-to-severe atopic dermatitis
Study compares eczema medications, finds upadacitinib 30 mg ranked highest for effectiveness
A network meta-analysis of 16,334 adults with moderate-to-severe atopic dermatitis compared approved systemic targeted therapies.
Upadacitinib 30 mg ranked highest for clearing skin and reducing itch among approved eczema medications in a new analysis of over 16,000 pat…
Placebo effect observed in double-blinded food challenges for dogs with atopic dermatitis
Study finds placebo effect complicates food allergy testing in dogs with skin condition
A randomized, double-blinded, placebo-controlled trial in 12 dogs with atopic dermatitis and adverse food reactions found 91.7% tested posit…
Most dogs with itchy skin reacted to food challenges, but half also reacted to a fake diet, showing the placebo effect makes allergy tests u…
Systematic review links PPARγ to atopic dermatitis pathogenesis and identifies it as a potential therapeutic target
Review suggests a protein target may be linked to eczema and could lead to new treatments
A systematic review synthesizes mechanistic evidence linking peroxisome proliferator-activated receptor gamma (PPARγ) to atopic dermatitis p…
A protein called PPARγ could be a key target for new eczema treatments, as it helps restore skin barrier function and regulate immune respon…
Topical PDE4 inhibitors show efficacy in pediatric atopic dermatitis meta-analysis
Could a new cream help kids with eczema find relief faster?
A meta-analysis of 5 RCTs (n=1877) in pediatric mild-to-moderate atopic dermatitis found topical PDE4 inhibitors were associated with higher…
A new class of eczema creams linked to faster relief and better skin clearance in kids, with no increase in side effects compared to standar…
Review suggests chemokine inhibition as prospective therapeutic target for atopic dermatitis
Review suggests chemokine pathways may be promising targets for eczema treatment
A review of basic and clinical research in patients with AD and AD model mice found that chemokine ligand-receptor interactions regulate imm…
Blocking specific immune signals in eczema skin reduced inflammation in mice, suggesting a new treatment path as human trials progress.
Research across Dermatitis
Related studies from across the Dermatitis family.
1 514 781 patients shows methylisothiazolinone allergy prevalence is 5.48% in dermatitis cases
Large review shows contact allergy to isothiazolinones affects many dermatitis patients
This systematic review and meta-analysis examined contact allergy prevalence to isothiazolinones in 1 514 781 dermatitis patients from 2000 …
A massive review of over 1.5 million patients found that contact allergy to isothiazolinones is common in dermatitis cases, with methylisoth…
Review highlights emerging mechanisms for allergic contact dermatitis management
Critical gaps remain in understanding allergic contact dermatitis sensitization thresholds
This narrative review discusses allergic contact dermatitis and notes critical gaps persist regarding tissue-resident memory T cells and pre…
A review of allergic contact dermatitis highlights emerging mechanisms that may support the development of more precise and effective therap…
Narrative review discusses ginsenosides for skin conditions including psoriasis and dermatitis with noted evidence gaps
Review of ginsenosides for skin conditions shows weak evidence and low absorption
This narrative review examines the use of ginsenosides for various skin conditions, including psoriasis, dermatitis, photoaging, chronic non…
A review of ginsenosides for skin issues like psoriasis and melanoma found the evidence is insufficient and absorption is low.
Questions about Atopic Dermatitis
Does swimming pool attendance increase asthma risk in children with atopic dermatitis?
Swimming pool attendance is linked to a small increase in asthma risk in children, but no clear link to atopic dermatitis itself.
Full answer →What is the national prevalence of atopic dermatitis in Ethiopia?
The national prevalence of atopic dermatitis in Ethiopia is approximately 12.75%, based on a systematic review and meta-analysis of 10 studies with 25,920 participants.
Full answer →Is dupilumab an effective treatment for pediatric atopic dermatitis?
Yes, dupilumab is an effective treatment for pediatric atopic dermatitis, with clinical trials showing significant improvement in skin clearance and itch reduction in children as young as 6 months.
Full answer →Does Staphylococcus aureus colonization make my atopic dermatitis worse?
Yes, Staphylococcus aureus colonization is moderately linked to worse atopic dermatitis severity, though this does not prove direct causation.
Full answer →